Viridian Therapeutics, Inc.\DE (VRDN) › Total AssetsViridian Therapeutics, Inc.\DE (VRDN) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $3.67M2014: $8.09M2015: $12.90M2016: $24.76M2017: $52.48M2018: $66.15M2019: $30.26M2020: $131.25M2021: $203.71M2022: $435.09M2023: $490.42M2024: $742.40M2025: $899.42M$899.42M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$899.42M+21.1%2024$742.40M+51.4%2023$490.42M+12.7%2022$435.09M+113.6%2021$203.71M+55.2%2020$131.25M+333.7%2019$30.26M-54.3%2018$66.15M+26.0%2017$52.48M+112.0%2016$24.76M+91.9%2015$12.90M+59.5%2014$8.09M+120.2%2013$3.67M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share